REFERENCES

1. NIH consensus conference. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314-9.

2. Pavri SN, Clune J, Ariyan S, Narayan D. Malignant melanoma: beyond the basics. Plast Reconstr Surg 2016;138:330e-40e.

3. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7-33.

4. Slominski RM, Raman C, Chen JY, Slominski AT. How cancer hijacks the body’s homeostasis through the neuroendocrine system. Trends Neurosci 2023;46:263-75.

5. Young JM, Goldman IR. Tumor metastasis to the heart. Circulation 1954;9:220-9.

6. Glancy DL, Roberts WC. The heart in malignant melanoma. A study of 70 autopsy cases. Am J Cardiol 1968;21:555-71.

7. Tse CS, Tan N, Idossa D, Click R. Cardiac melanoma: retrospective review of a rare disease at the Mayo clinic (1988-2015). Int J Cardiol 2017;249:383-6.

8. Wood A, Markovic SN, Best PJ, Erickson LA. Metastatic malignant melanoma manifesting as an intracardiac mass. Cardiovasc Pathol 2010;19:153-7.

9. Zitzelsberger T, Eigentler TK, Krumm P, et al. Imaging characteristics of cardiac metastases in patients with malignant melanoma. Cancer Imaging 2017;17:19.

10. Allen BC, Mohammed TL, Tan CD, Miller DV, Williamson EE, Kirsch JS. Metastatic melanoma to the heart. Curr Probl Diagn Radiol 2012;41:159-64.

11. Mousseaux E, Meunier P, Azancott S, Dubayle P, Gaux JC. Cardiac metastatic melanoma investigated by magnetic resonance imaging. Magn Reson Imaging 1998;16:91-5.

12. Restrepo CS, Largoza A, Lemos DF, et al. CT and MR imaging findings of malignant cardiac tumors. Curr Probl Diagn Radiol 2005;34:1-11.

13. Thant KP, Iliff J, Kepreotis SV, Prashar A, Sader M. Multimodal imaging and endomyocardial biopsy in the assessment and diagnosis of a cardiac melanoma. Circ Cardiovasc Imaging 2021;14:e012953.

14. Canver CC, Lajos TZ, Bernstein Z, DuBois DP, Mentzer RM Jr. Intracavitary melanoma of the left atrium. Ann Thorac Surg 1990;49:312-3.

15. Messner G, Harting MT, Russo P, et al. Surgical management of metastatic melanoma to the ventricle. Tex Heart Inst J 2003;30:218-20.

16. Rahouma M, Arisha MJ, Elmously A, et al. Cardiac tumors prevalence and mortality: a systematic review and meta-analysis. Int J Surg 2020;76:178-89.

17. Balinski AM, Vasbinder AL, Kerndt CC, et al. Metastatic melanoma of the heart: retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes. Cancer Med 2023;12:2356-67.

18. Bortolotti U, Tursi V, Milano A, Mazzucco A, Gallucci V. Intracardiac metastatic melanoma: report of a case mimicking a right atrial myxoma, with a review of the literature. Tex Heart Inst J 1990;17:136-8.

19. Burn PR, Chinn R, King DM. Right atrial metastatic melanoma detected by dynamic contrast enhanced spiral CT. Br J Radiol 1999;72:395-6.

20. Grazziotin MU, Turnipseed WD. Arterial tumor embolism caused by metastatic melanoma: case report and literature review. J Vasc Surg 2002;36:191-3.

21. Kaulen LD, Tietz F, Gradistanac T, Thiele H, Rommel KP. Cardiac melanoma metastases as a cause of sudden cardiac death. Clin Res Cardiol 2019;108:716-8.

22. Lee EY, Choi JO, Park HN, et al. Malignant melanoma of unknown primary origin presenting as cardiac metastasis. Korean Circ J 2012;42:278-80.

23. Liébana ES, González DJ, Martín M, Saiz A. Atypical presentation of cardiac metastasis of amelanotic melanoma. Int J Cardiovasc Imaging 2009;25:343-4.

24. Malouf JF, Thompson RC, Maples WJ, Wolfe JT. Diagnosis of right atrial metastatic melanoma by transesophageal echocardiographic-guided transvenous biopsy. Mayo Clin Proc 1996;71:1167-70.

25. Morosin M, Azzu A, Capoccia M, Rosendahl U. Extensive cardiac infiltrative melanoma. J Card Surg 2019;34:858-9.

26. Onan B, Onan IS, Polat B. Surgical resection of solitary metastasis of malignant melanoma to the right atrium. Tex Heart Inst J 2010;37:598-601.

27. Ozyuncu N, Sahin M, Altin T, Karaoguz R, Guldal M, Akyurek O. Cardiac metastasis of malignant melanoma: a rare cause of complete atrioventricular block. Europace 2006;8:545-8.

28. Poggi R, Pantaleo MA, Benedetti G, Biasco G. Cardiac metastasis of melanoma. Melanoma Res 2005;15:315-6.

29. Poulsen CB, Weile KS, Schmidt H, Poulsen SH. A case report: metastasis of melanoma to the heart in an era of immunotherapy. Eur Heart J Case Rep 2019;3:1-7.

30. Ramchand J, Wong GR, Yudi MB, Sylivris S. Cardiac metastatic melanoma. BMJ Case Rep 2016;2016:bcr2016215881.

31. Safa H, Glitza Oliva IC. Cardiac metastases in melanoma. N Engl J Med 2019;380:858.

32. Savoia P, Fierro MT, Zaccagna A, Bernengo MG. Metastatic melanoma of the heart. J Surg Oncol 2000;75:203-7.

33. Spiliopoulos K, Engels P, Kimpouri K, Floudas I, Salemis NS, Schmid FX. The current role of surgery in the treatment of cardiac metastases from malignant melanoma: an educational presentation. Braz J Cardiovasc Surg 2021;36:112-5.

34. Tas F, Mudun A, Kirma C. Cardiac involvement in melanoma: a case report and review of the literature. J Cancer Res Ther 2010;6:359-61.

35. Tesolin M, Lapierre C, Oligny L, Bigras JL, Champagne M. Cardiac metastases from melanoma. Radiographics 2005;25:249-53.

36. de Vasconcelos VT, Arias VE, Ikeda S. Cardiac metastasis of melanoma presenting as acute aortic occlusion. J Thromb Thrombolysis 2013;36:536-8.

37. Villa A, Eshja E, Dallavalle S, Bassi EM, Turco A. Cardiac metastases of melanoma as first manifestation of the disease. J Radiol Case Rep 2014;8:8-15.

38. Vukicevic P, Matkovic M, Markovic I, et al. Successfully resected cardiac metastatic melanoma in a lifesaving cardiac surgery: a case report. Heart Surg Forum 2020;23:E527-30.

39. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management. Lancet Oncol 2005;6:219-28.

40. O’Donnell DH, Abbara S, Chaithiraphan V, et al. Cardiac tumors: optimal cardiac MR sequences and spectrum of imaging appearances. AJR Am J Roentgenol 2009;193:377-87.

41. Holder WD Jr, White RL Jr, Zuger JH, Easton EJ Jr, Greene FL. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 1998;227:764-9; discussion 769-71.

42. El-shourbagy KH, Mashaly EM, Khodair SA, Houseni MM, Abou Khadrah RS. PET/CT in restaging, prognosis, and recurrence in patients with malignant melanoma. Egypt J Radiol Nucl Med 2020;51:167.

43. Dinnes J, Ferrante di Ruffano L, Takwoingi Y, et al. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma. Cochrane Database Syst Rev 2019;7:CD012806.

44. Buchbinder EI, Desai A. CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol 2016;39:98-106.

45. Hill MA, Kwon JH, Gerry B, et al. Immune privilege of heart valves. Front Immunol 2021;12:731361.

46. Barrueto L, Caminero F, Cash L, Makris C, Lamichhane P, Deshmukh RR. Resistance to checkpoint inhibition in cancer immunotherapy. Transl Oncol 2020;13:100738.

47. Herbst RS, Soria JC, Kowanetz M, et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 2014;515:563-7.

48. Long L, Zhang X, Chen F, et al. The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy. Genes Cancer 2018;9:176-89.

49. Das M, Zhu C, Kuchroo VK. Tim-3 and its role in regulating anti-tumor immunity. Immunol Rev 2017;276:97-111.